文献速递白血病MDS 与骨髓增殖性肿瘤

JMML肿瘤细胞通过过量产生IL-1β施加炎症应激破坏正常造血干细胞

JMML tumor cells disrupt normal hematopoietic stem cells by imposing inflammatory stress through overproduction of IL-1β.
PubMed 文献 · Blood Adv · 2022-01-01

该研究在髓系特异性表达Ptpn11E76K的小鼠JMML模型中,发现同一骨髓微环境中的造血干细胞被异常激活并耗竭,JMML/MPN细胞过量产生IL-1β而非其他炎症因子,敲除IL-1β受体可恢复HSC静息状态并挽救其耗竭,提示IL-1β信号是保护JMML正常造血发育的潜在治疗靶点。

要点

  • JMML/MPN细胞过量产生IL-1β,而非IL-6、TNF-α、IFN-γ、IL-1α等炎症因子
  • IL-1β受体缺失可恢复Ptpn11E76K/+小鼠HSC静息状态、正常化池大小并挽救耗竭
  • IL-1β信号是保护JMML正常造血发育的潜在治疗靶点

核心结论

  • JMML肿瘤细胞通过过量产生IL-1β对正常造血干细胞施加炎症应激,导致HSC失去静息并耗竭。
  • 敲除IL-1β受体可有效恢复HSC静息、正常化其池大小并挽救耗竭,提示IL-1β信号为潜在治疗靶点。

研究设计与样本

  • 在小鼠髓系谱系特异性诱导JMML最常见的Ptpn11E76K突变,同时保留HSC未受累。
  • 将野生型供体HSC与Ptpn11E76K/+骨髓细胞共移植入野生型小鼠,并进行共培养实验。
  • 构建Ptpn11E76K/+/IL-1R-/-双突变小鼠验证IL-1β受体缺失的作用。

主要发现

  • 髓系特异性Ptpn11E76K小鼠均一发展为JMML样MPN,同一骨髓微环境中HSC被异常激活并以自我更新为代价分化。
  • HSC失去静息并最终耗竭;野生型供体HSC与Ptpn11E76K/+骨髓细胞共移植后出现类似结果。
  • 共培养显示JMML/MPN细胞强烈加速小鼠和人正常造血干/祖细胞分化。
  • 细胞因子谱分析显示Ptpn11E76K/+ MPN细胞过量产生IL-1β,而非IL-6、TNF-α、IFN-γ、IL-1α或其他炎症因子。
  • Ptpn11E76K/+/IL-1R-/-双突变小鼠中IL-1β受体缺失恢复了HSC静息、正常化池大小并挽救耗竭。

临床怎么用

  • IL-1β信号可作为JMML中保护正常造血发育的潜在治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Development of normal blood cells is often suppressed in juvenile myelomonocytic leukemia (JMML), a myeloproliferative neoplasm (MPN) of childhood, causing complications and impacting therapeutic outcomes. However, the mechanism underlying this phenomenon remains uncharacterized. To address this question, we induced the most common mutation identified in JMML (Ptpn11E76K) specifically in the myeloid lineage with hematopoietic stem cells (HSCs) spared. These mice uniformly developed a JMML-like MPN. Importantly, HSCs in the same bone marrow (BM) microenvironment were aberrantly activated and differentiated at the expense of self-renewal. As a result, HSCs lost quiescence and became exhausted. A similar result was observed in wild-type (WT) donor HSCs when co-transplanted with Ptpn11E76K/+ BM cells into WT mice. Co-culture testing demonstrated that JMML/MPN cells robustly accelerated differentiation in mouse and human normal hematopoietic stem/progenitor cells. Cytokine profiling revealed that Ptpn11E76K/+ MPN cells produced excessive IL-1β, but not IL-6, T NF-α, IFN-γ, IL-1α, or other inflammatory cytokines. Depletion of the IL-1β receptor effectively restored HSC quiescence, normalized their pool size, and rescued them from exhaustion in Ptpn11E76K/+/IL-1R-/- double mutant mice. These findings suggest IL-1β signaling as a potential therapeutic target for preserving normal hematopoietic development in JMML.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Yan Y, Dong L, Chen C, et al. JMML tumor cells disrupt normal hematopoietic stem cells by imposing inflammatory stress through overproduction of IL-1β. Blood Adv. 2022. PMID: 34555844. doi:10.1182/bloodadvances.2021005089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。